Form 8-K - Current report:
SEC Accession No. 0001104659-20-096089
Filing Date
2020-08-17
Accepted
2020-08-17 16:03:02
Documents
2
Period of Report
2020-08-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2028821d1_8k.htm 8-K 18855
2 EXHIBIT 99.1 tm2028821d1_ex99-1.htm EX-99.1 20336
  Complete submission text file 0001104659-20-096089.txt   40466
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 201110088
SIC: 2834 Pharmaceutical Preparations